Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published Literature
- Supplementary File 1:
ZIP-Document (ZIP, 2844 KiB)
Manzo, C.; Isetta, M.; Natale, M.; Castagna, A. Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published Literature. Medicines 2020, 7, 68. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines7110068
Manzo C, Isetta M, Natale M, Castagna A. Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published Literature. Medicines. 2020; 7(11):68. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines7110068
Chicago/Turabian StyleManzo, Ciro; Isetta, Marco; Natale, Maria; Castagna, Alberto. 2020. "Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published Literature" Medicines 7, no. 11: 68. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines7110068